Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Front Pharmacol

From Bioblast
Journals in Bioblast
Journal title and website Frontiers in Pharmacology

Publications

 ReferencePublishedView
Pena-Corona 2023 Front PharmacolPeña-Corona SI, Hernández-Parra H, Bernal-Chávez SA, Mendoza-Muñoz N, Romero-Montero A, Del Prado-Audelo ML, Cortés H, Ateşşahin DA, Habtemariam S, Almarhoon ZM, Abdull Razis AF, Modu B, Sharifi-Rad J, Leyva-Gómez G (2023) Neopeltolide and its synthetic derivatives: a promising new class of anticancer agents. Front Pharmacol 14:1206334. https://doi.org/10.3389/fphar.2023.12063342023PMID: 37346293 Open Access
Vidimce 2021 Front PharmacolVidimce J, Pillay J, Shrestha N, Dong LF, Neuzil J, Wagner KH, Holland OJ, Bulmer AC (2021) Mitochondrial function, fatty acid metabolism, and body composition in the hyperbilirubinemic gunn rat. Front Pharmacol 12:586715.2021PMID: 33762933 Open Access
Gatti 2020 Front PharmacolGatti P, Ilamathi HS, Todkar K, Germain M (2020) Mitochondria targeted viral replication and survival strategies-prospective on SARS-CoV-2. Front Pharmacol 11:578599. https://doi.org/10.3389/fphar.2020.5785992020PMID: 32982760 Open Access
Ren 2017 Front PharmacolRen YJ, Wang XH, Ji C, Guan YD, Lu XJ, Liu XR, Zhang HH, Guo LC, Xu QH, Zhu WD, Ming ZJ, Yang JM, Cheng Y, Zhang Y (2017) Silencing of NAC1 expression induces cancer cells oxidative stress in hypoxia and potentiates the therapeutic activity of elesclomol. Front Pharmacol 8:804.2017PMID: 29163184 Open Access
Busanello 2017 Front PharmacolBusanello ENB, Marques AC, Lander N, de Oliveira DN, Catharino RR, Oliveira HCF, Vercesi AE (2017) Pravastatin chronic treatment sensitizes hypercholesterolemic mice muscle to mitochondrial permeability transition: protection by creatine or coenzyme Q10. Front Pharmacol 8:185.2017PMID: 28424622 Open Access